Welcome to the HNRC
Igor Grant Announced as New Chair of the Department of Psychiatry, University of California, San Diego
This message was sent on behalf of Dr. David Brenner, Vice Chancellor, UC San Diego Health Sciences and Dean of the School of Medicine, and Paul Viviano, Chief Executive Officer, UC San Diego Health System, to UC San Diego Health Sciences Faculty and Staff.
We are pleased to announce that Igor Grant, MD, FRCP(C), an internationally recognized neuropsychiatrist, has been named the new Chair of the Department of Psychiatry at UC San Diego School of Medicine. Dr. Grant has been at UC San Diego more than 40 years and has served as Executive Vice Chair in the department for the past 20. He will succeed Lewis Judd, MD, who is stepping down after 36 years in the position – the longest serving department chair in the history of the university.
David Moore Featured in UC Social Media Campaign Video "PrEParing for HIV"
UC researchers, including Dr. David Moore of the HIV Neurobehavioral Research Program, are conducting a 4-year study on pre-exposure prophylaxis (PrEP). PrEP is a prevention strategy for people at high risk for contracting HIV. Participants agree to take a Truvada pill daily to reduce their risk of getting infected by up to 99%. Adherence is critical for the method to be effective so participants in the study receive daily reminders to take their medications via text messages and their medication usage is tracked. Much of David Moore's recent work has focused on developing innovative, personalized, scalable text messaging interventions to improve antiretroviral medication adherence.
Click Here to watch the video.
Kaitlin Blackstone Announced as Society for Clinical Neuropsychology Blue Ribbon Award Winner
Kaitlin Blackstone’s Division 40 abstract submission for this year’s Society for Clinical Neuropsychology conference taking place June 25-28, 2014 was the top rated student author submission for scientific merit and impact. Her research investigated the NIH Toolbox Cognition Battery (NIH-TB-CB) as a possible brief neurocognitive screening instrument for use in a clinical setting to identify HIV+ individuals with evidence of some level of HIV-associated neurocognitive disorder (HAND).